CELG - Celgene Corporation

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
78.58B
Enterprise Value 3
87.46B
Trailing P/E
13.58
Forward P/E 1
8.90
PEG Ratio (5 yr expected) 1
0.67
Price/Sales (ttm)
4.63
Price/Book (mrq)
6.50
Enterprise Value/Revenue 3
5.15
Enterprise Value/EBITDA 6
9.73

Trading Information

Stock Price History

Beta (3Y Monthly) 1.41
52-Week Change 357.19%
S&P500 52-Week Change 313.25%
52 Week High 3110.69
52 Week Low 358.59
50-Day Moving Average 3103.20
200-Day Moving Average 397.10

Share Statistics

Avg Vol (3 month) 33.63M
Avg Vol (10 day) 34.63M
Shares Outstanding 5711.71M
Float 709.39M
% Held by Insiders 10.22%
% Held by Institutions 177.62%
Shares Short (Oct 31, 2019) 412.95M
Short Ratio (Oct 31, 2019) 43.45
Short % of Float (Oct 31, 2019) 41.85%
Short % of Shares Outstanding (Oct 31, 2019) 41.82%
Shares Short (prior month Sep 30, 2019) 411.76M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 26, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 34.62%
Operating Margin (ttm)49.05%

Management Effectiveness

Return on Assets (ttm)13.77%
Return on Equity (ttm)69.39%

Income Statement

Revenue (ttm)16.98B
Revenue Per Share (ttm)24.11
Quarterly Revenue Growth (yoy)16.10%
Gross Profit (ttm)14.06B
EBITDA 8.98B
Net Income Avi to Common (ttm)5.88B
Diluted EPS (ttm)8.13
Quarterly Earnings Growth (yoy)56.30%

Balance Sheet

Total Cash (mrq)10.9B
Total Cash Per Share (mrq)15.31
Total Debt (mrq)20.07B
Total Debt/Equity (mrq)166.04
Current Ratio (mrq)2.89
Book Value Per Share (mrq)16.99

Cash Flow Statement

Operating Cash Flow (ttm)8.16B
Levered Free Cash Flow (ttm)5.71B